ContraVir Pharmaceuticals Inc (OTCBB - OTCQB:CTRV)

2.68
Data as of Jan 26
 -0.06 / -2.19%
Today’s Change
0.01
Today|||52-Week Range
3.10
+20.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization0.001.3K----
 
 
 
Operating ExpensesGross Income0.00-1.3K----
 
 
General Expenses140.2K1.7M----
 
 
 
Research And Development17.7K314.2K----
 
 
 
Total Operating Expenses140.2K1.7M----
 
 
 
 
Non-Operating ExpensesOperating Income-140.2K-1.7M----
 
 
 
Extraordinary Charge0.00-3.6M----
 
 
Interest Expense On Debt328.0012.9K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-140.5K-5.3M----
 
 
 
Net Income-140.5K-5.3M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.0M12.8M----
 
 
 
Shares To Calculate EPS Diluted9.0M12.8M----
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.41----
 
 
 
EPS Diluted-$0.02-$0.41----
 
 
 
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.